- Onyx Pharma presented at the Robert W Baird Healthcare conference - click here for full presenter schedule and links to my notes.
- ONXX is developing carfilzomib for multiple myeloma, is on the verge of completing the NDA filing - uses Captisol technology licensed from Ligand Pharma LGND.
- See my webcast notes below: